Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bluestem Biosciences is developing proprietary microbial strains and fermentation processes to produce sustainable, bio-based commodity chemicals—such as precursors for acrylics and plastics—using agricultural feedstocks via anaerobic fermentation. The company aims to reduce greenhouse gas emissions by over 75% compared to petrochemical methods. As of mid-2024, they are in the research/discovery phase with no commercial products yet but have filed multiple patents and received SBIR Phase I awards for their technology development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bluestem Biosciences.